Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Device Type
3.2. Snippet by Distribution Channel
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising incidence of diabetes
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High costs associated with diabetes devices
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Device Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
6.1.2. Market Attractiveness Index, By Device Type
6.2. Blood Glucose Monitoring (BGM) Devices*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Self-Monitoring Devices
6.2.3.1. Blood Glucose Meters
6.2.3.2. Testing Strips
6.2.3.3. Lancets
6.2.4. Continuous Glucose Monitoring Devices
6.2.4.1. Sensors
6.2.4.2. Durables
6.2.4.3. Others
6.3. Insulin Delivery Devices
6.3.1. Insulin Pumps
6.3.2. Insulin Pens
6.3.3. Insulin Syringes
6.3.4. Jet Injectors
6.3.5. Others
6.4. Others
7. By Distribution Channel
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
7.1.2. Market Attractiveness Index, By Distribution Channel
7.2. Hospital Pharmacies*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Retail Pharmacies
7.4. Diabetes Clinics/Centers
7.5. Online Pharmacies
7.6. Others
8. Competitive Landscape
8.1. Competitive Scenario
8.2. Market Positioning/Share Analysis
8.3. Mergers and Acquisitions Analysis
9. Company Profiles
9.1. Novo Nordisk A/S*
9.1.1. Company Overview
9.1.2. Product Portfolio and Description
9.1.3. Financial Overview
9.1.4. Key Developments
9.2. Abbott Laboratories
9.3. Nipro Medical Europe
9.4. Afon Technology Ltd
9.5. GlucoRx Limited
9.6. Ascensia Diabetes Care UK Limited
9.7. SIBIONICS
9.8. Roche Diabetes Care
9.9. Kinetik Medical Devices Limited
9.10. Dexcom, Inc. (*LIST NOT EXHAUSTIVE)
10. Appendix
10.1. About Us and Services
10.2. Contact Us